Form 4: American Healthcare REIT Executive Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Gabriel M. Willhite, Chief Operating Officer of American Healthcare REIT, reports acquisition and disposal of common stock and restricted stock units on March 14, 2025.

Summary

  • On March 14, 2025, Gabriel M. Willhite, the Chief Operating Officer of American Healthcare REIT, engaged in transactions involving the company's stock.
  • Willhite acquired 2,197 shares of common stock through the vesting of restricted stock units.
  • The company withheld 1,116 shares to cover Willhite's tax obligations related to the vesting of performance-based restricted stock units at a price of $28.89.
  • Following these transactions, Willhite directly owns 139,310 shares of American Healthcare REIT.
  • Willhite also owns 2,197 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's alignment with shareholder interests.

Comparison to Industry Standards

  • Monitoring insider transactions is a common practice in financial analysis.
  • Comparing Willhite's holdings and transactions to those of executives at similar healthcare REITs (e.g., Welltower, Ventas, Healthpeak Properties) can provide insights into relative executive compensation and ownership stakes.
  • Analyzing the vesting schedules and performance metrics of restricted stock units against industry benchmarks can reveal how American Healthcare REIT incentivizes its executives.

Stakeholder Impact

  • The transactions have a minor impact on shareholders as they reflect executive compensation and alignment with company performance.
  • Employees may be indirectly affected by the vesting of executive stock options, as it relates to overall company performance and incentives.

Key Dates

DateDescription
October 4, 2021Performance-based restricted stock units ('PRSUs') were granted under the Issuer's Second Amended and Restated 2015 Incentive Plan.
March 14, 2025Earliest transaction date; restricted stock units vested and shares were acquired and disposed of to cover tax obligations.
March 17, 2025Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.